Stanford University; Division of Pediatric Stem Cell Transplant & Regenerative Medicine
				
				Palo Alto, California 94304
We've found
        3 trials
        at this facility
      	
	Endocrinology, Pharmacology / Toxicology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Immunology / Infectious Diseases, Oncology Clinical Trial
	
Updated: 9/29/2017
  
  
  Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 9/29/2017
Click here to add this to my saved trials
	    
	 
  	
	Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	